DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Octreotide Acetate is a drug marketed by Fresenius Kabi Usa, Heritage Pharms Inc, Sagent Pharms Inc, Sun Pharm Inds, Teva Pharms Usa, West-ward Pharms Int, Wockhardt Usa, and Mylan Institutional. and is included in eighteen NDAs.
The generic ingredient in OCTREOTIDE ACETATE is octreotide acetate. There are twenty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
A generic version of OCTREOTIDE ACETATE was approved as octreotide acetate by WEST-WARD PHARMS INT on April 8th, 2005.
Summary for OCTREOTIDE ACETATE
|Finished Product Suppliers / Packagers:||5|
|Raw Ingredient (Bulk) Api Vendors:||45|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for OCTREOTIDE ACETATE|
|DailyMed Link:||OCTREOTIDE ACETATE at DailyMed|
Recent Clinical Trials for OCTREOTIDE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
|National Institute for Health Research, United Kingdom||Phase 2|
|University College, London||Phase 2|
|NeuroEndocrine Tumor Research Foundation (NETRF)||Phase 1|